MedPath

Investigator initiated study for comparison of ART outcome in 0.2 mg GnRH agonist trigger

Not Applicable
Conditions
Health Condition 1: O090- Supervision of pregnancy with history of infertility
Registration Number
CTRI/2022/07/044258
Lead Sponsor
Indira IVF Hospital Udaipur
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Age 25- 40 years

2. Antral follicle count on day 2 of menses less than 5

3.AMH less than 1.2 ng per dl

Exclusion Criteria

1. BMI; >= 30 kg/m2

2. Presence of endocrine disorders; (uncontrolled diabetes mellitus, / hyperprolactinemia, thyroid dysfunction,

3. Congenital adrenal hyperplasia, Cushing syndrome, or polycystic ovary syndrome

4. Previous major uterine surgery

5. Donor oocyte cycle.

6. Gestational carrier

7. Fertility preservation.

8. Adenomyosis

9. Endometriosis

10. Premature ovarian failure.

11. Thin endometrium <6mm after 21 days of HRT (oestradiol valerate).

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Percentage of mature oocytes retrieval <br/ ><br> <br/ ><br>Timepoint: On the day of ovum pick-up <br/ ><br>10- 15 days of start of simulation <br/ ><br> <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
Follicle oocyte index <br/ ><br>Timepoint: On the day of ovum pick-up <br/ ><br>10- 15 days of start of simulation;Clinical pregnancy rateTimepoint: 4-6 weeks after embryo transfer;Implantation rateTimepoint: 4- 6 weeks after embryo transfer;OHSS occurrence rateTimepoint: 4 weeks from ovum pick up;Ongoing pregnancy rateTimepoint: 12th week of gestation;Oocyte retrieval rateTimepoint: On the day of ovum pick-up <br/ ><br>10- 15 days of start of simulation
© Copyright 2025. All Rights Reserved by MedPath